SOLESENCE, INC. SLSN
Nasdaq · stock · Perfumes, Cosmetics & Other Toilet Preparations · website · IPO 1997-11-28
SOLESENCE, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $62.1M | $52.3M | $37.3M | $37.3M | $29.5M | $17.1M | $12.5M | $14.2M | $12.5M | $10.8M |
| Gross profit | $16.1M | $16.2M | $7.8M | $8.4M | $8.7M | $6.0M | $2.6M | $3.3M | $3.9M | $3.2M |
| R&D expense | $4.1M | $3.8M | $3.8M | $3.0M | $2.2M | $1.6M | $1.9M | $2.1M | $1.7M | $1.6M |
| SG&A expense | $10.4M | $7.2M | $7.5M | $7.6M | $3.9M | $2.9M | $3.5M | $3.3M | $2.9M | $3.0M |
| Operating income | $1.6M | $5.1M | -$3.5M | -$2.3M | $2.6M | $1.5M | -$2.8M | -$2.0M | -$772,000 | -$1.3M |
| Interest expense | — | — | $838,000 | $382,000 | $1.2M | $496,000 | $210,000 | $58,000 | $34,000 | $15,000 |
| Income tax | $73,000 | $227,000 | $6,000 | -$17,000 | $37,000 | — | — | $0 | $0 | — |
| Net income | $1.8M | $4.2M | -$4.4M | -$2.6M | $2.3M | $989,000 | -$3.0M | -$2.1M | -$789,000 | -$1.3M |
| EPS (diluted) | $0.02 | $0.07 | $-0.09 | $-0.05 | $0.05 | $0.03 | $-0.08 | — | — | — |
| Operating cash flow | -$8.6M | $2.0M | -$2.0M | -$1.6M | $2.3M | -$2.1M | -$2.8M | -$1.3M | -$960,000 | -$241,000 |
| Free cash flow | — | -$2.6M | -$3.1M | -$4.5M | $447,000 | -$2.9M | -$3.5M | -$1.5M | -$1.2M | -$369,000 |
| Cash & equivalents | $1.3M | $1.4M | $1.7M | $2.2M | $657,000 | $957,000 | $1.2M | $1.3M | $2.0M | $1.8M |
| Inventory | $18.5M | $20.3M | $10.0M | $8.8M | $6.1M | $4.3M | $2.6M | $2.2M | $1.4M | $772,000 |
| Total assets | $50.1M | $50.0M | $32.9M | $33.6M | $28.4M | $13.5M | $9.4M | $6.6M | $6.3M | $4.8M |
| Shareholders' equity | $17.6M | $14.9M | $1.9M | $5.6M | $7.5M | $2.7M | $1.5M | $1.4M | $3.2M | $2.8M |
Growth · year-over-year · Revenue CAGR 21.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +18.6% | +40.4% | -0.1% | +26.6% | +72.1% | +36.9% | -11.9% | +13.8% | +15.7% | +4.6% |
| Net income growth | -57.7% | — | — | -213.1% | +134.6% | — | — | — | — | — |
| EPS growth | -71.4% | — | — | -200.0% | +66.7% | — | — | — | — | — |
| Free cash flow growth | — | — | — | -1100.7% | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.